BIOTW

Biotech Acquisition Company Warrant
BIOTW

Delisted

BIOTW was delisted on the 2nd of February, 2023.

51 hedge funds and large institutions have $3.8M invested in Biotech Acquisition Company Warrant in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
+3
Holders Change %
+6.25%
% of All Funds
0.88%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
5
Closed
Calls
$5.72M
Puts
Net Calls
+$5.72M
Net Calls Change
+$4K
Name Holding Trade Value Shares
Change
Shares
Change %
HF
26
HRT Financial
New York
$4K
CP
27
Centerbridge Partners
New York
$4K
Walleye Capital
28
Walleye Capital
New York
$4K
WA
29
Whitebox Advisors
Minnesota
$3K
CCM
30
Context Capital Management
California
$3K
CCA
31
Castle Creek Arbitrage
Colorado
$3K
Jane Street
32
Jane Street
New York
$3K
CS
33
Clear Street
New York
$3K
UBS Group
34
UBS Group
Switzerland
$2K -$115 -1,449 -5%
SSA
35
Schonfeld Strategic Advisors
New York
$2K
Walleye Trading
36
Walleye Trading
New York
$2K
WAM
37
Wolverine Asset Management
Illinois
$2K
State of Wisconsin Investment Board
38
State of Wisconsin Investment Board
Wisconsin
$2K
AA
39
AQR Arbitrage
Connecticut
$2K
MC
40
Meteora Capital
Florida
$1K -$258 -5,128 -21%
BCM
41
BCK Capital Management
Connecticut
$1K
CC
42
Centiva Capital
New York
$1K
Bank of America
43
Bank of America
North Carolina
$1K
BCM
44
Basso Capital Management
Connecticut
$1K
OCAM
45
Owl Creek Asset Management
New York
$1K
OAC
46
OMERS Administration Corp
Ontario, Canada
$1K
AA
47
Ancora Advisors
Ohio
$1K
PFM
48
Privium Fund Management
Netherlands
$1K
PCM
49
Prelude Capital Management
New York
$1K +$1K +18,731 New